Human Brain Vascular Pericytes (HBVP)

Human Brain Vascular Pericytes (HBVP)

Cat.No.: CSC-7825W

Species: Human

Source: Brain

Cell Type: Pericyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7825W
Description
Human Brain Vascular Pericytes (HBVP) from Creative Bioarray are isolated from human brain tissue. HBVP are cryopreserved at secondary culture after purification and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HBVP are characterized by immunofluorescent method with antibodies to α-smooth muscle actin. HBVP are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HBVP are guaranteed to further expand for 15 population doublings in the condition provided by Creative Bioarray.
Species
Human
Source
Brain
Cell Type
Pericyte
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Brain Vascular Pericytes (HBVPs) are primarily located along the capillary basement membrane in the central nervous system, closely linked with endothelial cells to form a complex network. Cerebrovascular structures rely on these components to cover the endothelial layer. HBVPs possess smooth muscle-like contractile abilities which help maintain cerebrovascular stability by controlling vascular contraction and dilation and they can be found in tissues with high vascularization such as the placenta. Under certain conditions their pluripotent nature enables them to transform into either neural cells or vascular cells. Neuroscience research utilizes HBVPs to investigate diseases such as Alzheimer's, Parkinson's, and multiple sclerosis while also examining how drugs impact blood-brain barrier stability and vascular operations. The ability of these cells to differentiate between multiple cell types enables them to play crucial roles in neural regeneration and tissue repair processes.

(A–C) Cultured primary human brain pericytes at varying confluency levels; (D) primary human brain pericytes stained with a monoclonal antibody for neural/glial antigen-2 (NG2) proteoglycan.Fig. 1. (A–C) Primary human brain pericytes in culture, from low to high confluency; (D) primary human brain pericytes stained with a monoclonal antibody against neural/glial antigen-2 (NG2) proteoglycan (Alcendor D, 2020).

The Role of Immunosenescence in Cerebral Small Vessel Disease: A Review

International Journal of Molecular Sciences | DOI | Paper |

Background

This review examines the role of immunosenescence and inflammaging in age-related cerebral small vessel disease (ArCSVD). It discusses how aging-related immune dysregulation, chronic low-grade inflammation, endothelial dysfunction, oxidative stress, blood-brain barrier leakage, and microglial impairment create a self-amplifying cycle that promotes white matter lesions and vascular dementia. The authors highlight early detection using MRI markers and serum inflammatory biomarkers, and explore therapeutic strategies targeting immunosenescence, including drugs used in multiple sclerosis and pericyte-based approaches. The review emphasizes a holistic approach to prevent ArCSVD progression.

Key Findings

The review finds that immunosenescence and inflammaging are central to ArCSVD pathogenesis. Aging causes deterioration of immune organs, dysregulated innate and adaptive immunity, and a chronic low-grade inflammatory state. Senescent immune cells, including microglia, release inflammatory mediators, reactive oxygen species, and senescence-associated secretory phenotype factors, driving endothelial dysfunction and blood-brain barrier leakage. This allows CNS antigens into circulation, recruiting peripheral immune cells into the brain and establishing a self-perpetuating inflammatory circuit. The authors report that early detection of BBB leakage, white matter hyperintensities, and microstructural damage via conventional MRI, diffusion tensor imaging, and in vitro BBB chips may identify patients at risk. Serum markers such as CRP, IL-6, homocysteine, and von Willebrand factor may also aid early diagnosis. Therapeutic strategies include controlling vascular risk factors, statins, ACE inhibitors, cilostazol, and immunomodulatory drugs like fingolimod, natalizumab, and dimethyl fumarate. Pericyte transplantation is proposed as a promising approach.

Contribution

Creative Bioarray is cited for providing Human Brain Vascular Pericytes (HBVP), a key cell type discussed in the context of pericyte-mediated microvascular function, BBB maintenance, and therapeutic potential in ArCSVD. Their product supports neurovascular research, helping elucidate pericyte roles and development of pericyte transplantation strategies for cerebral small vessel disease.

Aging causes alterations in the innate and adaptive immune system that lead to increased oxidative stress and endothelial dysfunction
Fig. 1. Aging causes alterations in the innate and adaptive immune system that lead to increased oxidative stress and endothelial dysfunction

PET Micro- and Nanoplastic Particles Affect the Oxygen Consumption Rate (OCR) and Extracellular Acidification (ECAR) of Human Brain Vascular Pericytes

The biological effects of nanoplastics and microplastics create significant health concerns because they spread through environments and food chains before reaching the human body. The ability of these particles to cross the blood-brain barrier leads to oxidative stress and mitochondrial dysfunction. Given that pericytes play a vital role in maintaining the integrity and function of the blood-brain barrier, Gettings et al. evaluated whether polyethylene terephthalate (PET) particles influence these critical brain cells.

Cell counting assay was performed for pericyte exposed to PET for 3, 6 and 10 days. There is a no change of absorbance intensity of pericytes suggesting no change in cell viability following 3 days, 6 days, and 10 days treatment of PET at 50 μg/ml. The Agilent Seahorse XFp Mito Stress Test assessed mitochondrial respiration by measuring OCR (pmol/min) and ECAR (mpH/min). Exposure to PET did not affect ECAR compared to the control regardless of duration, though an interaction was noted at 3 days (Fig. 1A). No significant ECAR changes were observed at 6 days (Fig. 1B) or 10 days (Fig. 1C). However, PET significantly reduced OCR after 3 days of exposure (Fig. 1D), with no significant changes detected at 6 days (Fig. 1E) or 10 days (Fig. 1F).

Kinetics of extracellular acidification rate (ECAR, A) and oxygen consumption rate (OCR, B): ECAR and OCR in pericytes treated with control (round orange) or 50 μg/ml PET (square green) for 3, 6, and 10 days.Fig. 2. Extracellular acidification rate (ECAR, A) and oxygen consumption rate (OCR, B) kinetics: ECAR and OCR of pericytes exposed to control (round orange) or 50 μg/ml PET (square green) for 3, 6 and 10 days (Gettings SM, Timburry W, et al., 2024).

Effects of oIAPP on HBVP in the Microvascular Model

IAPP aggregates in diabetes and Alzheimer's disease, affecting brain pericytes involved in blood-brain barrier integrity. Despite its association with vascular issues, the impact of IAPP on capillary contraction is less understood. Nu?ez-Diaz et al. uses an in vitro microvasculature model, co-culturing human brain vascular pericytes with endothelial cells, to assess oIAPP's effects on pericyte morphology and contractility.

Co-culturing endothelial cells with HBVP resulted in self-assembled cell clusters connected by branches, forming capillary-like structures (CLS) without a lumen (Fig. 2A, B). These CLS comprised HBVPs closely associated with elongated endothelial cells, with many HBVP located peripherally along the branches (Fig. 2C, D). After 22-hour stimulation with oligomeric IAPP (oIAPP), HBVPs more frequently adopted a round shape (Fig. 2C, D). The proportion of round HBVP significantly increased compared to the vehicle condition, which mostly contained elongated HBVP (Fig. 2C–E). Trypan blue staining showed a low number of dead, round HBVP (<20%), with no significant difference between oIAPP and vehicle treatments (Fig. 2H).

Impact of oIAPP on HBVP within the microvascular model.Fig. 3. Effects of oIAPP on HBVP in the microvascular model (Nu?ez-Diaz C, Pocevi?iūt? D, et al., 2023).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products